nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—type 2 diabetes mellitus	0.191	0.602	CbGaD
Cilostazol—CYP3A4—type 2 diabetes mellitus	0.127	0.398	CbGaD
Cilostazol—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.028	0.0623	CbGbCtD
Cilostazol—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.028	0.0623	CbGbCtD
Cilostazol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0263	0.0585	CbGbCtD
Cilostazol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0223	0.0498	CbGbCtD
Cilostazol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0223	0.0498	CbGbCtD
Cilostazol—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.021	0.0467	CbGbCtD
Cilostazol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0206	0.0459	CbGbCtD
Cilostazol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0199	0.0443	CbGbCtD
Cilostazol—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.019	0.0424	CbGbCtD
Cilostazol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.017	0.0378	CbGbCtD
Cilostazol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0167	0.0373	CbGbCtD
Cilostazol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0157	0.0349	CbGbCtD
Cilostazol—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.015	0.0334	CbGbCtD
Cilostazol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0149	0.0333	CbGbCtD
Cilostazol—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0142	0.0315	CbGbCtD
Cilostazol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0137	0.0304	CbGbCtD
Cilostazol—CYP3A5—Losartan—type 2 diabetes mellitus	0.013	0.0289	CbGbCtD
Cilostazol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0129	0.0287	CbGbCtD
Cilostazol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0123	0.0275	CbGbCtD
Cilostazol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0119	0.0266	CbGbCtD
Cilostazol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0114	0.0255	CbGbCtD
Cilostazol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0241	CbGbCtD
Cilostazol—CYP2C19—Losartan—type 2 diabetes mellitus	0.0105	0.0233	CbGbCtD
Cilostazol—CYP1A2—Losartan—type 2 diabetes mellitus	0.00964	0.0215	CbGbCtD
Cilostazol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00818	0.0182	CbGbCtD
Cilostazol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00784	0.0175	CbGbCtD
Cilostazol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00784	0.0175	CbGbCtD
Cilostazol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00741	0.0165	CbGbCtD
Cilostazol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00552	0.0123	CbGbCtD
Cilostazol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00505	0.0113	CbGbCtD
Cilostazol—PDE3A—penis—type 2 diabetes mellitus	0.00235	0.37	CbGeAlD
Cilostazol—Aripiprazole—ADRA2A—type 2 diabetes mellitus	0.000629	0.42	CrCbGaD
Cilostazol—Aripiprazole—HTR2C—type 2 diabetes mellitus	0.000579	0.387	CrCbGaD
Cilostazol—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000434	0.0683	CbGeAlD
Cilostazol—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.000377	0.0595	CbGeAlD
Cilostazol—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000371	0.0585	CbGeAlD
Cilostazol—PDE3A—adipose tissue—type 2 diabetes mellitus	0.000333	0.0525	CbGeAlD
Cilostazol—Aripiprazole—CYP3A4—type 2 diabetes mellitus	0.000289	0.193	CrCbGaD
Cilostazol—CYP3A7—liver—type 2 diabetes mellitus	0.000283	0.0446	CbGeAlD
Cilostazol—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000241	0.038	CbGeAlD
Cilostazol—PDE3A—liver—type 2 diabetes mellitus	0.000233	0.0368	CbGeAlD
Cilostazol—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000223	0.0351	CbGeAlD
Cilostazol—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000179	0.0283	CbGeAlD
Cilostazol—CYP3A5—kidney—type 2 diabetes mellitus	0.000158	0.0249	CbGeAlD
Cilostazol—CYP3A5—pancreas—type 2 diabetes mellitus	0.000157	0.0247	CbGeAlD
Cilostazol—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000154	0.0242	CbGeAlD
Cilostazol—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000142	0.0224	CbGeAlD
Cilostazol—CYP2C19—liver—type 2 diabetes mellitus	0.000127	0.0199	CbGeAlD
Cilostazol—CYP3A4—kidney—type 2 diabetes mellitus	0.000118	0.0187	CbGeAlD
Cilostazol—CYP2D6—kidney—type 2 diabetes mellitus	0.000116	0.0184	CbGeAlD
Cilostazol—CYP1A2—liver—type 2 diabetes mellitus	0.000103	0.0163	CbGeAlD
Cilostazol—CYP3A5—liver—type 2 diabetes mellitus	9.97e-05	0.0157	CbGeAlD
Cilostazol—Muscle spasms—Losartan—type 2 diabetes mellitus	9.36e-05	0.000536	CcSEcCtD
Cilostazol—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.34e-05	0.000535	CcSEcCtD
Cilostazol—Chest pain—Metformin—type 2 diabetes mellitus	9.33e-05	0.000535	CcSEcCtD
Cilostazol—Myalgia—Metformin—type 2 diabetes mellitus	9.33e-05	0.000535	CcSEcCtD
Cilostazol—Malaise—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.000534	CcSEcCtD
Cilostazol—Vertigo—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.000532	CcSEcCtD
Cilostazol—Headache—Pioglitazone—type 2 diabetes mellitus	9.29e-05	0.000532	CcSEcCtD
Cilostazol—Syncope—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000531	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.27e-05	0.000531	CcSEcCtD
Cilostazol—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.00053	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.23e-05	0.000529	CcSEcCtD
Cilostazol—Discomfort—Metformin—type 2 diabetes mellitus	9.22e-05	0.000528	CcSEcCtD
Cilostazol—Nausea—Glipizide—type 2 diabetes mellitus	9.19e-05	0.000527	CcSEcCtD
Cilostazol—Vomiting—Glimepiride—type 2 diabetes mellitus	9.18e-05	0.000526	CcSEcCtD
Cilostazol—Hypotension—Valsartan—type 2 diabetes mellitus	9.18e-05	0.000526	CcSEcCtD
Cilostazol—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.15e-05	0.000524	CcSEcCtD
Cilostazol—Pain—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.000524	CcSEcCtD
Cilostazol—Rash—Glimepiride—type 2 diabetes mellitus	9.1e-05	0.000522	CcSEcCtD
Cilostazol—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.09e-05	0.000521	CcSEcCtD
Cilostazol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000521	CcSEcCtD
Cilostazol—Rash—Sitagliptin—type 2 diabetes mellitus	9.07e-05	0.00052	CcSEcCtD
Cilostazol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.07e-05	0.000519	CcSEcCtD
Cilostazol—Erythema multiforme—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000519	CcSEcCtD
Cilostazol—Headache—Glimepiride—type 2 diabetes mellitus	9.04e-05	0.000518	CcSEcCtD
Cilostazol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.03e-05	0.000517	CcSEcCtD
Cilostazol—Cough—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.000517	CcSEcCtD
Cilostazol—Headache—Sitagliptin—type 2 diabetes mellitus	9.02e-05	0.000517	CcSEcCtD
Cilostazol—Anaemia—Losartan—type 2 diabetes mellitus	9e-05	0.000515	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.95e-05	0.000513	CcSEcCtD
Cilostazol—Oedema—Metformin—type 2 diabetes mellitus	8.95e-05	0.000513	CcSEcCtD
Cilostazol—Tinnitus—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000512	CcSEcCtD
Cilostazol—Hypertension—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000512	CcSEcCtD
Cilostazol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.91e-05	0.000511	CcSEcCtD
Cilostazol—Infection—Metformin—type 2 diabetes mellitus	8.89e-05	0.000509	CcSEcCtD
Cilostazol—Insomnia—Valsartan—type 2 diabetes mellitus	8.88e-05	0.000509	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.84e-05	0.000507	CcSEcCtD
Cilostazol—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000505	CcSEcCtD
Cilostazol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.81e-05	0.000505	CcSEcCtD
Cilostazol—Chest pain—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000505	CcSEcCtD
Cilostazol—Myalgia—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000505	CcSEcCtD
Cilostazol—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000505	CcSEcCtD
Cilostazol—Shock—Metformin—type 2 diabetes mellitus	8.8e-05	0.000504	CcSEcCtD
Cilostazol—Insomnia—Orlistat—type 2 diabetes mellitus	8.78e-05	0.000503	CcSEcCtD
Cilostazol—Malaise—Losartan—type 2 diabetes mellitus	8.78e-05	0.000503	CcSEcCtD
Cilostazol—Anxiety—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000503	CcSEcCtD
Cilostazol—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.77e-05	0.000503	CcSEcCtD
Cilostazol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.76e-05	0.000502	CcSEcCtD
Cilostazol—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.76e-05	0.000502	CcSEcCtD
Cilostazol—Vertigo—Losartan—type 2 diabetes mellitus	8.75e-05	0.000501	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000501	CcSEcCtD
Cilostazol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.74e-05	0.000501	CcSEcCtD
Cilostazol—Syncope—Losartan—type 2 diabetes mellitus	8.73e-05	0.0005	CcSEcCtD
Cilostazol—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000499	CcSEcCtD
Cilostazol—Leukopenia—Losartan—type 2 diabetes mellitus	8.71e-05	0.000499	CcSEcCtD
Cilostazol—Discomfort—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000498	CcSEcCtD
Cilostazol—Skin disorder—Metformin—type 2 diabetes mellitus	8.69e-05	0.000498	CcSEcCtD
Cilostazol—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.65e-05	0.000495	CcSEcCtD
Cilostazol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000495	CcSEcCtD
Cilostazol—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.61e-05	0.000493	CcSEcCtD
Cilostazol—Palpitations—Losartan—type 2 diabetes mellitus	8.6e-05	0.000493	CcSEcCtD
Cilostazol—Nausea—Glimepiride—type 2 diabetes mellitus	8.58e-05	0.000491	CcSEcCtD
Cilostazol—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.56e-05	0.00049	CcSEcCtD
Cilostazol—Nausea—Sitagliptin—type 2 diabetes mellitus	8.55e-05	0.00049	CcSEcCtD
Cilostazol—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.54e-05	0.00049	CcSEcCtD
Cilostazol—Asthenia—Glyburide—type 2 diabetes mellitus	8.54e-05	0.000489	CcSEcCtD
Cilostazol—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000489	CcSEcCtD
Cilostazol—Anorexia—Metformin—type 2 diabetes mellitus	8.53e-05	0.000489	CcSEcCtD
Cilostazol—Cough—Losartan—type 2 diabetes mellitus	8.49e-05	0.000487	CcSEcCtD
Cilostazol—Urticaria—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000487	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.48e-05	0.000486	CcSEcCtD
Cilostazol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.45e-05	0.000484	CcSEcCtD
Cilostazol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.45e-05	0.000484	CcSEcCtD
Cilostazol—Oedema—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000484	CcSEcCtD
Cilostazol—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.44e-05	0.000483	CcSEcCtD
Cilostazol—Pruritus—Glyburide—type 2 diabetes mellitus	8.42e-05	0.000483	CcSEcCtD
Cilostazol—Infection—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.00048	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.38e-05	0.00048	CcSEcCtD
Cilostazol—Hypotension—Metformin—type 2 diabetes mellitus	8.36e-05	0.000479	CcSEcCtD
Cilostazol—Shock—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000476	CcSEcCtD
Cilostazol—Pain—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000476	CcSEcCtD
Cilostazol—Myalgia—Losartan—type 2 diabetes mellitus	8.29e-05	0.000475	CcSEcCtD
Cilostazol—Chest pain—Losartan—type 2 diabetes mellitus	8.29e-05	0.000475	CcSEcCtD
Cilostazol—Arthralgia—Losartan—type 2 diabetes mellitus	8.29e-05	0.000475	CcSEcCtD
Cilostazol—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.28e-05	0.000474	CcSEcCtD
Cilostazol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000474	CcSEcCtD
Cilostazol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000474	CcSEcCtD
Cilostazol—Anxiety—Losartan—type 2 diabetes mellitus	8.26e-05	0.000473	CcSEcCtD
Cilostazol—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000472	CcSEcCtD
Cilostazol—Rash—Bromocriptine—type 2 diabetes mellitus	8.21e-05	0.000471	CcSEcCtD
Cilostazol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.2e-05	0.00047	CcSEcCtD
Cilostazol—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.00047	CcSEcCtD
Cilostazol—Discomfort—Losartan—type 2 diabetes mellitus	8.19e-05	0.000469	CcSEcCtD
Cilostazol—Headache—Bromocriptine—type 2 diabetes mellitus	8.16e-05	0.000467	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.15e-05	0.000467	CcSEcCtD
Cilostazol—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.15e-05	0.000467	CcSEcCtD
Cilostazol—Anorexia—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000461	CcSEcCtD
Cilostazol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.03e-05	0.00046	CcSEcCtD
Cilostazol—Paraesthesia—Metformin—type 2 diabetes mellitus	8.03e-05	0.00046	CcSEcCtD
Cilostazol—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.02e-05	0.00046	CcSEcCtD
Cilostazol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8e-05	0.000458	CcSEcCtD
Cilostazol—Dyspnoea—Metformin—type 2 diabetes mellitus	7.97e-05	0.000457	CcSEcCtD
Cilostazol—Oedema—Losartan—type 2 diabetes mellitus	7.94e-05	0.000455	CcSEcCtD
Cilostazol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.94e-05	0.000455	CcSEcCtD
Cilostazol—Infection—Losartan—type 2 diabetes mellitus	7.89e-05	0.000452	CcSEcCtD
Cilostazol—Hypotension—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000452	CcSEcCtD
Cilostazol—Dyspepsia—Metformin—type 2 diabetes mellitus	7.87e-05	0.000451	CcSEcCtD
Cilostazol—Shock—Losartan—type 2 diabetes mellitus	7.82e-05	0.000448	CcSEcCtD
Cilostazol—Urticaria—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000447	CcSEcCtD
Cilostazol—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.79e-05	0.000446	CcSEcCtD
Cilostazol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.78e-05	0.000446	CcSEcCtD
Cilostazol—Decreased appetite—Metformin—type 2 diabetes mellitus	7.78e-05	0.000446	CcSEcCtD
Cilostazol—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000445	CcSEcCtD
Cilostazol—Tachycardia—Losartan—type 2 diabetes mellitus	7.75e-05	0.000444	CcSEcCtD
Cilostazol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000444	CcSEcCtD
Cilostazol—Nausea—Bromocriptine—type 2 diabetes mellitus	7.74e-05	0.000443	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.72e-05	0.000442	CcSEcCtD
Cilostazol—Urticaria—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000442	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000441	CcSEcCtD
Cilostazol—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.67e-05	0.00044	CcSEcCtD
Cilostazol—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.67e-05	0.00044	CcSEcCtD
Cilostazol—Asthenia—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.00044	CcSEcCtD
Cilostazol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000434	CcSEcCtD
Cilostazol—Anorexia—Losartan—type 2 diabetes mellitus	7.57e-05	0.000434	CcSEcCtD
Cilostazol—Vomiting—Glyburide—type 2 diabetes mellitus	7.57e-05	0.000434	CcSEcCtD
Cilostazol—Pruritus—Gliclazide—type 2 diabetes mellitus	7.56e-05	0.000433	CcSEcCtD
Cilostazol—Malaise—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000431	CcSEcCtD
Cilostazol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000431	CcSEcCtD
Cilostazol—Rash—Glyburide—type 2 diabetes mellitus	7.51e-05	0.00043	CcSEcCtD
Cilostazol—Dermatitis—Glyburide—type 2 diabetes mellitus	7.5e-05	0.00043	CcSEcCtD
Cilostazol—Vertigo—Ramipril—type 2 diabetes mellitus	7.5e-05	0.00043	CcSEcCtD
Cilostazol—Syncope—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000429	CcSEcCtD
Cilostazol—CYP3A4—liver—type 2 diabetes mellitus	7.48e-05	0.0118	CbGeAlD
Cilostazol—Leukopenia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000428	CcSEcCtD
Cilostazol—Headache—Glyburide—type 2 diabetes mellitus	7.46e-05	0.000427	CcSEcCtD
Cilostazol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.43e-05	0.000426	CcSEcCtD
Cilostazol—Hypotension—Losartan—type 2 diabetes mellitus	7.42e-05	0.000425	CcSEcCtD
Cilostazol—Palpitations—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000423	CcSEcCtD
Cilostazol—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.37e-05	0.000422	CcSEcCtD
Cilostazol—CYP2D6—liver—type 2 diabetes mellitus	7.36e-05	0.0116	CbGeAlD
Cilostazol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.00042	CcSEcCtD
Cilostazol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.34e-05	0.00042	CcSEcCtD
Cilostazol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000419	CcSEcCtD
Cilostazol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.31e-05	0.000419	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.000418	CcSEcCtD
Cilostazol—Cough—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000417	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.24e-05	0.000415	CcSEcCtD
Cilostazol—Pain—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000414	CcSEcCtD
Cilostazol—Insomnia—Losartan—type 2 diabetes mellitus	7.19e-05	0.000412	CcSEcCtD
Cilostazol—Paraesthesia—Losartan—type 2 diabetes mellitus	7.13e-05	0.000409	CcSEcCtD
Cilostazol—Urticaria—Metformin—type 2 diabetes mellitus	7.11e-05	0.000407	CcSEcCtD
Cilostazol—Myalgia—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000407	CcSEcCtD
Cilostazol—Arthralgia—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000407	CcSEcCtD
Cilostazol—Chest pain—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000407	CcSEcCtD
Cilostazol—Dyspnoea—Losartan—type 2 diabetes mellitus	7.08e-05	0.000406	CcSEcCtD
Cilostazol—Anxiety—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000406	CcSEcCtD
Cilostazol—Nausea—Glyburide—type 2 diabetes mellitus	7.07e-05	0.000405	CcSEcCtD
Cilostazol—Abdominal pain—Metformin—type 2 diabetes mellitus	7.07e-05	0.000405	CcSEcCtD
Cilostazol—Dizziness—Gliclazide—type 2 diabetes mellitus	7.07e-05	0.000405	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000404	CcSEcCtD
Cilostazol—Asthenia—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000404	CcSEcCtD
Cilostazol—Discomfort—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000402	CcSEcCtD
Cilostazol—Dyspepsia—Losartan—type 2 diabetes mellitus	6.99e-05	0.000401	CcSEcCtD
Cilostazol—Asthenia—Orlistat—type 2 diabetes mellitus	6.96e-05	0.000399	CcSEcCtD
Cilostazol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000399	CcSEcCtD
Cilostazol—Pruritus—Valsartan—type 2 diabetes mellitus	6.95e-05	0.000398	CcSEcCtD
Cilostazol—Decreased appetite—Losartan—type 2 diabetes mellitus	6.91e-05	0.000396	CcSEcCtD
Cilostazol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000395	CcSEcCtD
Cilostazol—Pruritus—Orlistat—type 2 diabetes mellitus	6.87e-05	0.000393	CcSEcCtD
Cilostazol—Oedema—Ramipril—type 2 diabetes mellitus	6.81e-05	0.00039	CcSEcCtD
Cilostazol—Vomiting—Gliclazide—type 2 diabetes mellitus	6.8e-05	0.000389	CcSEcCtD
Cilostazol—Pain—Losartan—type 2 diabetes mellitus	6.79e-05	0.000389	CcSEcCtD
Cilostazol—Rash—Gliclazide—type 2 diabetes mellitus	6.74e-05	0.000386	CcSEcCtD
Cilostazol—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.73e-05	0.000386	CcSEcCtD
Cilostazol—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.72e-05	0.000385	CcSEcCtD
Cilostazol—Urticaria—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000384	CcSEcCtD
Cilostazol—Shock—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000384	CcSEcCtD
Cilostazol—Headache—Gliclazide—type 2 diabetes mellitus	6.7e-05	0.000384	CcSEcCtD
Cilostazol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000383	CcSEcCtD
Cilostazol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000382	CcSEcCtD
Cilostazol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000382	CcSEcCtD
Cilostazol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000382	CcSEcCtD
Cilostazol—Tachycardia—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000381	CcSEcCtD
Cilostazol—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.64e-05	0.00038	CcSEcCtD
Cilostazol—Skin disorder—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000379	CcSEcCtD
Cilostazol—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.55e-05	0.000375	CcSEcCtD
Cilostazol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.5e-05	0.000372	CcSEcCtD
Cilostazol—Dizziness—Valsartan—type 2 diabetes mellitus	6.5e-05	0.000372	CcSEcCtD
Cilostazol—Anorexia—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000372	CcSEcCtD
Cilostazol—Dizziness—Orlistat—type 2 diabetes mellitus	6.42e-05	0.000368	CcSEcCtD
Cilostazol—Asthenia—Metformin—type 2 diabetes mellitus	6.42e-05	0.000368	CcSEcCtD
Cilostazol—Hypotension—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000365	CcSEcCtD
Cilostazol—Nausea—Gliclazide—type 2 diabetes mellitus	6.35e-05	0.000364	CcSEcCtD
Cilostazol—Pruritus—Metformin—type 2 diabetes mellitus	6.33e-05	0.000363	CcSEcCtD
Cilostazol—Urticaria—Losartan—type 2 diabetes mellitus	6.31e-05	0.000362	CcSEcCtD
Cilostazol—Abdominal pain—Losartan—type 2 diabetes mellitus	6.28e-05	0.00036	CcSEcCtD
Cilostazol—Body temperature increased—Losartan—type 2 diabetes mellitus	6.28e-05	0.00036	CcSEcCtD
Cilostazol—Vomiting—Valsartan—type 2 diabetes mellitus	6.25e-05	0.000358	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000356	CcSEcCtD
Cilostazol—Rash—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000355	CcSEcCtD
Cilostazol—Dermatitis—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000355	CcSEcCtD
Cilostazol—Vomiting—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000354	CcSEcCtD
Cilostazol—Insomnia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000353	CcSEcCtD
Cilostazol—Headache—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000353	CcSEcCtD
Cilostazol—Diarrhoea—Metformin—type 2 diabetes mellitus	6.12e-05	0.000351	CcSEcCtD
Cilostazol—Rash—Orlistat—type 2 diabetes mellitus	6.12e-05	0.000351	CcSEcCtD
Cilostazol—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.12e-05	0.00035	CcSEcCtD
Cilostazol—Dermatitis—Orlistat—type 2 diabetes mellitus	6.11e-05	0.00035	CcSEcCtD
Cilostazol—Headache—Orlistat—type 2 diabetes mellitus	6.08e-05	0.000348	CcSEcCtD
Cilostazol—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000348	CcSEcCtD
Cilostazol—Asthenia—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000347	CcSEcCtD
Cilostazol—Dyspepsia—Ramipril—type 2 diabetes mellitus	6e-05	0.000344	CcSEcCtD
Cilostazol—Pruritus—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000342	CcSEcCtD
Cilostazol—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000339	CcSEcCtD
Cilostazol—Dizziness—Metformin—type 2 diabetes mellitus	5.92e-05	0.000339	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000337	CcSEcCtD
Cilostazol—Nausea—Valsartan—type 2 diabetes mellitus	5.83e-05	0.000334	CcSEcCtD
Cilostazol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000331	CcSEcCtD
Cilostazol—Nausea—Orlistat—type 2 diabetes mellitus	5.77e-05	0.00033	CcSEcCtD
Cilostazol—Asthenia—Losartan—type 2 diabetes mellitus	5.7e-05	0.000327	CcSEcCtD
Cilostazol—Vomiting—Metformin—type 2 diabetes mellitus	5.69e-05	0.000326	CcSEcCtD
Cilostazol—Rash—Metformin—type 2 diabetes mellitus	5.64e-05	0.000323	CcSEcCtD
Cilostazol—Dermatitis—Metformin—type 2 diabetes mellitus	5.63e-05	0.000323	CcSEcCtD
Cilostazol—Pruritus—Losartan—type 2 diabetes mellitus	5.62e-05	0.000322	CcSEcCtD
Cilostazol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000322	CcSEcCtD
Cilostazol—Headache—Metformin—type 2 diabetes mellitus	5.6e-05	0.000321	CcSEcCtD
Cilostazol—Dizziness—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.00032	CcSEcCtD
Cilostazol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000319	CcSEcCtD
Cilostazol—Diarrhoea—Losartan—type 2 diabetes mellitus	5.44e-05	0.000311	CcSEcCtD
Cilostazol—Urticaria—Ramipril—type 2 diabetes mellitus	5.41e-05	0.00031	CcSEcCtD
Cilostazol—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000309	CcSEcCtD
Cilostazol—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000309	CcSEcCtD
Cilostazol—Vomiting—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000308	CcSEcCtD
Cilostazol—Rash—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000305	CcSEcCtD
Cilostazol—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000305	CcSEcCtD
Cilostazol—Nausea—Metformin—type 2 diabetes mellitus	5.31e-05	0.000304	CcSEcCtD
Cilostazol—Headache—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000303	CcSEcCtD
Cilostazol—Dizziness—Losartan—type 2 diabetes mellitus	5.25e-05	0.000301	CcSEcCtD
Cilostazol—Vomiting—Losartan—type 2 diabetes mellitus	5.05e-05	0.000289	CcSEcCtD
Cilostazol—Nausea—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000287	CcSEcCtD
Cilostazol—Rash—Losartan—type 2 diabetes mellitus	5.01e-05	0.000287	CcSEcCtD
Cilostazol—Dermatitis—Losartan—type 2 diabetes mellitus	5e-05	0.000287	CcSEcCtD
Cilostazol—Headache—Losartan—type 2 diabetes mellitus	4.98e-05	0.000285	CcSEcCtD
Cilostazol—Asthenia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.00028	CcSEcCtD
Cilostazol—Pruritus—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000276	CcSEcCtD
Cilostazol—Nausea—Losartan—type 2 diabetes mellitus	4.72e-05	0.00027	CcSEcCtD
Cilostazol—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000267	CcSEcCtD
Cilostazol—Dizziness—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000258	CcSEcCtD
Cilostazol—Vomiting—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000248	CcSEcCtD
Cilostazol—Rash—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000246	CcSEcCtD
Cilostazol—Dermatitis—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000246	CcSEcCtD
Cilostazol—Headache—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000245	CcSEcCtD
Cilostazol—Nausea—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000232	CcSEcCtD
Cilostazol—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.91e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.91e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	6.87e-06	0.000134	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.84e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	6.79e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	6.79e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	6.78e-06	0.000132	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.77e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.74e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.74e-06	0.000132	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.65e-06	0.00013	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.65e-06	0.00013	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.64e-06	0.00013	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.63e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.62e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.58e-06	0.000128	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.52e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.49e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.49e-06	0.000127	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.48e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.48e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.48e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.47e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.44e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.44e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.43e-06	0.000126	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.38e-06	0.000124	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.37e-06	0.000124	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.33e-06	0.000124	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.32e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.32e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.32e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.32e-06	0.000123	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.3e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.3e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.27e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.27e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.27e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.25e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.23e-06	0.000122	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.2e-06	0.000121	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.16e-06	0.00012	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.14e-06	0.00012	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.14e-06	0.00012	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.1e-06	0.000119	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.1e-06	0.000119	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.08e-06	0.000119	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.06e-06	0.000118	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.01e-06	0.000117	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6e-06	0.000117	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.89e-06	0.000115	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.82e-06	0.000114	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.81e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.81e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.81e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.78e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.75e-06	0.000112	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.71e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.71e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.7e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.66e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.65e-06	0.00011	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.64e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.63e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.63e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.61e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5.57e-06	0.000109	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.56e-06	0.000108	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.54e-06	0.000108	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.53e-06	0.000108	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.53e-06	0.000108	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.52e-06	0.000108	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.52e-06	0.000108	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.51e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.49e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.49e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.49e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.49e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.48e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.48e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.45e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.44e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.42e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.35e-06	0.000105	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.33e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.33e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.33e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.33e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.31e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.29e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.28e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.25e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.25e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.21e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.12e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.11e-06	9.97e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	5.05e-06	9.85e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.04e-06	9.83e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.04e-06	9.83e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5e-06	9.77e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.94e-06	9.63e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.92e-06	9.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.92e-06	9.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.92e-06	9.6e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.91e-06	9.58e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.83e-06	9.43e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.83e-06	9.42e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.83e-06	9.42e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.79e-06	9.34e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.75e-06	9.28e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.75e-06	9.27e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.72e-06	9.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.72e-06	9.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.72e-06	9.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.7e-06	9.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.68e-06	9.14e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.68e-06	9.12e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.66e-06	9.09e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.64e-06	9.05e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.61e-06	8.99e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.5e-06	8.78e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.5e-06	8.78e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.45e-06	8.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.43e-06	8.65e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.42e-06	8.62e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.38e-06	8.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.34e-06	8.48e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.34e-06	8.48e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.34e-06	8.47e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.34e-06	8.47e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.34e-06	8.47e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.32e-06	8.43e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.32e-06	8.43e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.3e-06	8.39e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.27e-06	8.33e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.27e-06	8.33e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.26e-06	8.32e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.26e-06	8.32e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.25e-06	8.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.23e-06	8.26e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.23e-06	8.26e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.23e-06	8.26e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.21e-06	8.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.21e-06	8.21e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.19e-06	8.18e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.14e-06	8.08e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.13e-06	8.07e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.09e-06	7.97e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.08e-06	7.97e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.06e-06	7.92e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.03e-06	7.87e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.03e-06	7.86e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.98e-06	7.77e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.95e-06	7.71e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.92e-06	7.65e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.87e-06	7.55e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.87e-06	7.55e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.86e-06	7.52e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.8e-06	7.41e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.8e-06	7.41e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.8e-06	7.41e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.8e-06	7.41e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.76e-06	7.33e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.73e-06	7.27e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.71e-06	7.24e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.69e-06	7.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.68e-06	7.18e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.68e-06	7.18e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.68e-06	7.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.66e-06	7.14e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.65e-06	7.12e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.62e-06	7.06e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.61e-06	7.05e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.61e-06	7.05e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.6e-06	7.03e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.56e-06	6.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.56e-06	6.94e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.51e-06	6.84e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.49e-06	6.81e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.49e-06	6.81e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.49e-06	6.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.47e-06	6.78e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.43e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.43e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.41e-06	6.66e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.38e-06	6.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.35e-06	6.53e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.32e-06	6.49e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.31e-06	6.46e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.29e-06	6.43e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.29e-06	6.43e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.28e-06	6.4e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.27e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.27e-06	6.37e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-06	6.23e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.18e-06	6.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.14e-06	6.13e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.14e-06	6.12e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.08e-06	6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.01e-06	5.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.96e-06	5.77e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.89e-06	5.63e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.86e-06	5.59e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.84e-06	5.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.84e-06	5.54e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.83e-06	5.52e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.83e-06	5.51e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.82e-06	5.5e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.82e-06	5.5e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.81e-06	5.48e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.79e-06	5.44e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.77e-06	5.41e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.71e-06	5.28e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.7e-06	5.27e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.7e-06	5.27e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.63e-06	5.14e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.59e-06	5.06e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.58e-06	5.04e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.53e-06	4.94e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.52e-06	4.92e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	4.84e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	4.84e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.47e-06	4.82e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.46e-06	4.79e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.44e-06	4.77e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.42e-06	4.73e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.4e-06	4.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.33e-06	4.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.28e-06	4.45e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	4.43e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.22e-06	4.33e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.21e-06	4.31e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.2e-06	4.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.17e-06	4.24e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.17e-06	4.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.14e-06	4.18e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.1e-06	4.1e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.1e-06	4.1e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.92e-06	3.75e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.89e-06	3.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.85e-06	3.61e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.7e-06	3.31e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-06	3.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	2.9e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	2.42e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	2.23e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.66e-07	1.89e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.46e-07	1.46e-05	CbGpPWpGaD
